Corbion NV CRBN
EURONEXT · Netherlands · Consumer Non-Durables
€22.52-0.20 (-0.88%)
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Accelerating demand for clean-label food preservation, natural acidulants, and bio-based materials highlighted by ADM’s fermentation scale-ups, Corbion’s next-gen lactic acid technology rollouts, and bio-based citric acid expansions across Cargill and Jungbunzlauer is propelling the global market from $11.1 billion in 2026 to a projected $18.2 billion by 2035. This 210-page report delivers an in-depth analysis of acidulant types (citric acid, lactic acid, citrate and lactate salts), end-use indu
HONOLULU, July 08, 2026--The financing is designed to accelerate KAS's transition from technology development to commercial production and sales.
The annual Corbion General Shareholders Meeting held on 13 May 2026 approved the appointments of Per Falholt and Bob Elfring as members of the Supervisory Board. Per Falholt brings over 40 years of experience in research and development, innovation, and leadership in the biotechnology and life sciences sectors. He currently serves as Operating Partner at Forbion and is co-founder and Chief Scientific Officer at 21st.BIO. He also holds several board positions and previously led global R&D at Novo
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.